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For a number of years  the writers, in conjunction with Dr. Wade 
H. Brown and Dr. Louise Pearce, have been engaged in the synthesis 
of certain new types of organic arsenic compounds for the treatment 
of  experimental  trypanosome and  spirochete infections.  Although 
considerable of our effort has been given to the study of trivalent 
arsenicals our attention was at first confined to the development of 
compounds containing arsenic in the pentavalent form as presented 
by the arsonic adds.  This group seemed best suited for the synthetic 
procedure which was employed and afforded the best opportunity for 
obtaining such information as  to the relationship between chemical 
structure and biological action as would be useful for further work. 
Again it was felt that if a practicable and efficient drug could be found 
within this group it would go far toward eliminating certain of the 
well known practical disadvantages of the usual arseno compounds, 
for  as  an  arsonic acid it should form soluble and  stable  salts  and 
perhaps offer fewer of the preparative uncertainties than have been 
the experience with trivalent arsenicals. 
In the course of these studies a  number of substances have been 
prepared which have given interesting experimental results.  However, 
those obtained with one in particular, the sodium salt of N-phenyl- 
glycineamide-p-arsonic acid 
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were  such  as  to demand  special attention.  The simplicity of this 
compound,  the ease of preparing it, its relatively inexpensive char- 
acter, stability,  and solubility, and its favorable biological behavior, 
warrant  a  publication  of  results.  We wish therefore to present in 
conjunction with the following biological papers  of Dr.  Brown and 
Dr. Pearce,  the  facts  as  to  the  preparation  and properties of the 
substance which will be appropriate in the present place.  A some- 
what fuller description of the substance and  of related  compounds 
has appeared elsewhere.  I 
Phenylglycine-p-arsordc acid, and its homologue, o-methylphenyl- 
glycine-p-arsordc  acid,  have  already  been  described  in  German 
Patent,  No.  204,664.  These  substances,  of interest solely  as  the 
source  of  the  arsenophenylglycines which  were  obtained  by  their 
reduction, were readily prepared  by the interaction of the sodium 
salts  of the amino-arylarsordc acids and sodium  chloroacetate.  In 
our investigations we have found that a  reaction of this type, with 
a-halogenacylarMno  compounds,  XCH~CONHR,  instead  of  the 
a-halogen  acids,  XCH~COOH,  is  capable  of  practically  unlimited 
extension and has  rendered possible  the preparation of a new series 
of aromatic arsenic compounds.  In these substances the free car- 
boxyl group of the above glycines has been  changed  to  the amide 
or substituted amide group. 
N-Phenylglydneamide-p-arsordc acid,  ~ prepared by the methods to 
be  described  in  the  experimental  part,  readily yields  a  colorless, 
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crystalline  sodium  salt  which  is  extremely  easily  soluble in  water, 
forming neutral  solutions,  which  are perfectly stable.  In fact a  10 
per cent solution may be boiled a  reasonable length of time without 
appreciable cleavage of ammonia or arsenic. 
The  materials  required  and  the  method  of preparation  are  such 
that  the  large  scale  production  of the  substance  should  offer little 
difficulty. 
EX.PERrM-ENTAL. 
N-(  Phenyl-4-Arsonic  A cid)-Glycineamide (  N-Phenylglycineamide-p- 
Arsonic Acid).--Of the two methods used for the preparation of this 
substance that described first is more direct. 
434 gin. of arsanilic acid were dissolved in 2 liters of normal sodium 
hydroxide  solution.  After  the  addition  of  375 gin.  of chloroaceta- 
mide the mixture was boiled under a reflux condenser for 45 minutes, 
the  clear  solution  setting  to  a  solid  mass  of the  crude  product  on 
cooling.  75 cc. of concentrated hydrochloric acid were added to the 
cold mixture to hold any unchanged arsanilic acid in solution and the 
substance was then filtered off and carefully washed with cold water. 
For purification it was suspended in sufficient water to form a  thin 
paste and  carefully treated,  with  stirring,  with  25  per  cent sodium 
hydroxide  solution  until  the  acid  was  completely  dissolved.  The 
filtered solution was then treated with an excess of acetic acid where- 
upon  the  substance  separated  as  minute,  lustrous  plates.  After 
filtering,  washing  thoroughly,  and  drying,  the  yield  was  300  gin. 
The  acid  is  very  sparingly  soluble  in  cold  water  but  dissolves 
readily  on  heating.  It  separates  from the hot aqueous solution in 
aggregates  of long,  thin  plates.  It  is  insoluble  in  methyl  alcohol, 
acetone, or chloroform and  sparingly in hot methyl or ethyl alcohol, 
but dissolves in boiling acetic acid.  It is sparingly soluble in dilute 
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hydrochloric acid but dissolves readily in the strong acid, its behavior 
showing it to be a  weaker base than  arsanilic  acid.  On boiling its 
solution  in sodium  hydroxide  ammonia  is  evolved.  When  rapidly 
heated in an open capillary tube it darkens and softens at 280°C., but 
does not melt. 
0.1405 gin. of substance; 12.35 cc. of N (22.0°C., 761 mm.). 
0.3205 gin. of substance; 0.1832 gin. of Mg~As~O~. 
Calculated for CsHllOaN~s: N, 10.22 per cent; As, 27.33 per cent. 
Found:  N, 10.18 per cent; As, 27.59 per cent. 
Sodium Salt.--The pure acid is suspended in enough water to form 
a thick paste and carefully treated with 25 per cent sodium hydroxide 
solution until completely dissolved and the solution reacts neutral to 
litmus.  Two volumes of alcohol are  then  added,  the  pure  sodium 
salt quickly separating  as thin,  nacreous plates.  After filtering and 
washing  with  85  per  cent  alcohol it  is  air-dried  and  then  contains 
one-half  molecule  of  water  of  crystallization.  The  sodium  salt  is 
extremely  soluble in  cold  water,  the  solution  reacting  neutral  to 
litmus.  The apparatus, filter paper, water,  etc., used in the prepara- 
tion of this salt must be free from calcium; otherwise a  precipitate of 
the  insoluble  calcium  salt will contaminate  solutions of  the sodium 
salt. 
0.3921 gin. of air-dry  substance, at  100°C. in vacuo over H2SO4; 0.0117 gm. 
loss. 
Calculated for CsH1004N2AsNa. ½  H20: H20, 2.95 per cent. 
Found:  H20, 2.98 per cent. 
Anhydrous:  0,1503 gin. of substance; 12.45 cc. of N(25.0°C., 762 ram.). 
0.2300 gm. of substance; 0.1195 gin. of Mg~As2OT. 
Calculated for CsH1004N2AsNa: N, 9.46 per cent; As, 25.32 per cent. 
Found:  N, 9.52 per cent; As, 25.08 per cent. 
The  potassium  and  ammonium  salts  were prepared  in  the  same 
way as the sodium salt and  form thin,  glistening,  hexagonal,  micro- 
scopic platelets.  On adding a calcium chloride solution to a solution 
of  the  sodium  salt  the  calcium  salt  gradually  separates  as  micro- 
scopic wedge-shaped prisms,  containing  no  water  of  crystallization. 
Magnesia mixture  causes no precipitate  in the cold, but on warming 
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metal  salts  give  immediate  precipitates,  the  silver  salt  forming 
aggregates of thin, microscopic needles. 
N-Phenylglycineamide-p-arsonic acid was also prepared as follows 
from  N-phenylglycine methyl  ester-p-arsonic  acid  by the action of 
ammonia. 
N-(Phenyl-4-Arsonic Acid)-Glycine  Methyl  Ester.---40  gm.  of  N- 
phenylglycine-p-arsonic acid  s were treated with 120 gm. of dry methyl 
alcohol and 4  gm.  of concentrated sulfuric acid.  The mixture was 
boiled under a reflux condenser for 2 hours.  The ester separated on 
cooling  and  scratching,  the  precipitation  being  completed  by  the 
addition of water.  The filtered, washed, and dried product weighed 
38  gin.  It can be recrystallized from hot water or hot 95  per cent 
alcohol, separating from the former as microscopic needles and thin 
plates.  It is  very sparingly soluble in  cold water,  cold alcohol,  or 
boiling acetone, and is fairly easily soluble in methyl alcohol, especially 
on  warming.  When  rapidly  heated  it  softens  and  darkens  above 
200°C. and decomposes at about 285 °. 
0.1560 gln. of substance; 7.0 cc. of N (21.0°C., 747 mm.). 
0.3135 gm. of substance; 0.1665 gm. of Mgg.As2OT. 
Calculated for CgHz2OsNAs: N, 4.84 per cent; As, 25.94 per cent. 
Found:  N, 5.12 per cent; As, 25.63 per cent. 
The ester was converted into the amide as follows:  10 gin. of the 
ester were slowly added, with stirring, to 30  cc. of well chilled, con- 
centrated ammonia.  At first a  thick paste of the ammonium salt of 
the ester was formed, but on allowing the mixture to  rise to  room 
temperature the reaction proceeded with formation of a  clear solu- 
tion.  After  24  hours  the  excess  of  ammonia was removed, pref- 
erably in  vacuo.  On  diluting  with  water,  filtering,  and  acidifying 
with  acetic  acid,  N-phenylglycineamide-p-arsonic acid  separated  in 
characteristic form.  This was  purified  as  described  above  and  was 
identical  in  every way  with  the  product  obtained  by  the  direct 
method.  The yield was 80 per cent of the theory. 
0.1297 gin. of substance; 11.5 cc. of N (19.5°C., 742 ram.). 
Calculated for CsHnO4N2As: N, 10.22 per cent. 
Found: N, 10.11 per cent. 
s German Patent, No. 204,664. 